Meridian Bioscience (FRA:MR4) EPS (Basic) : €0.88 (TTM As of Sep. 2022)

View and export this data going back to 1986. Start your Free Trial

What is Meridian Bioscience EPS (Basic)?

Meridian Bioscience's basic earnings per share (Basic EPS) for the three months ended in Sep. 2022 was €0.13. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Sep. 2022 was €0.88.

Meridian Bioscience's EPS (Diluted) for the three months ended in Sep. 2022 was €0.13. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2022 was €0.87.

Meridian Bioscience's EPS without NRI for the three months ended in Sep. 2022 was €0.13. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Sep. 2022 was 0.87.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Meridian Bioscience EPS (Basic) Historical Data

The historical data trend for Meridian Bioscience's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Meridian Bioscience EPS (Basic) Chart

Meridian Bioscience Annual Data

Trend

Sep13

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

EPS (Basic)

Get a 7-Day Free Trial

0.48

0.52

0.92

1.40

0.98

Meridian Bioscience Quarterly Data
	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
EPS (Basic)	Get a 7-Day Free Trial															0.13	0.31	0.60	-0.16	0.13

Meridian Bioscience EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Meridian Bioscience's Basic EPS for the fiscal year that ended in Sep. 2022 is calculated as

Basic EPS (A: Sep. 2022 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(42.884	-	0)	/	43.583
	=	0.98

Meridian Bioscience's Basic EPS for the quarter that ended in Sep. 2022 is calculated as

Basic EPS (Q: Sep. 2022 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(5.762	-	0)	/	43.754
	=	0.13

EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.88

Meridian Bioscience (FRA:MR4) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Meridian Bioscience EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Meridian Bioscience's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Meridian Bioscience (FRA:MR4) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Meridian Bioscience Inc (FRA:MR4) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

3471 River Hills Drive, Cincinnati, OH, USA, 45244

Website

https://www.meridianbioscience.com

Meridian Bioscience Inc is an integrated life science company. It develops and distributes diagnostic tests and reagents, as well as biologic substances used by pharmaceutical and biotechnology companies. Its Diagnostics segment manufactures tests primarily for gastrointestinal, viral, respiratory, & parasitic infectious diseases. Its testing platforms include isothermal DNA amplification, rapid immunoassays, and enzyme-linked immunoassays. The Life sciences segment sells b-antigens, antibodies, and reagents in bulk to other diagnostic manufacturers, the agriculture industry, and researchers. It also manufactures proteins that biopharmaceutical companies use in new drugs and vaccines. The entity has a business presence in the US and other countries.

Meridian Bioscience (FRA:MR4) Headlines

No Headlines